Search Legislation

Commission Delegated Regulation (EU) No 1062/2014Show full title

Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)

 Help about what version

What Version

 Help about opening options

Opening OptionsExpand opening options

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Changes to legislation:

There are outstanding changes by UK legislation not yet made to Commission Delegated Regulation (EU) No 1062/2014. Those changes will be listed when you open the content using the Table of Contents below. Any changes that have already been made to the legislation appear in the content and are referenced with annotations. Help about Changes to Legislation

  1. Introductory Text

  2. CHAPTER 1 SUBJECT MATTER AND DEFINITIONS

    1. Article 1.Subject matter

    2. Article 2.Definitions

  3. CHAPTER 2 PROCESS FOR EVALUATION OF DOSSIERS

    1. Article 3.Application for approval or inclusion in the Simplified Active Substance List

    2. Article 4.Acceptance of applications

    3. Article 5.Validation of applications for approval or inclusion in category B of the Simplified Active Substance List

    4. Article 6.Evaluation of applications

    5. Article 6a. Applications for which the competent authority of the United Kingdom was the evaluating competent authority before 30 March 2019

    6. Article 7.Opinion of the competent authority

    7. Article 8.Active substances which are candidates for substitution

    8. Article 9.Decision

  4. CHAPTER 3 CHANGES OF ELEMENTS OF THE REVIEW PROGRAMME

    1. Article 10.Joining or replacing participants by mutual agreement

    2. Article 11.Participants' withdrawal

    3. Article 12.Consequences of a timely withdrawal

    4. Article 13.Redefinition of active substances

    5. Article 14.Taking over the role of participant

    6. Article 15.Substance/product-type combinations eligible for inclusion in the review programme

    7. Article 16.Declaration of interest to notify

    8. Article 17.Notification procedure

    9. Article 18.Inclusion in the review programme

    10. Article 19.Information on substances no longer supported under the review programme

    11. Article 20.... Decisions on substances no longer supported under the review programme

  5. CHAPTER 4 TRANSITIONAL MEASURES

    1. Article 21.Transitional measures for substances referred to in Article 15

    2. Article 22.Essential use

    3. Article 22A.Transitional measures for ongoing applications submitted before IP completion day

    4. Article 22B.Declaration of interest to notify

    5. Article 22C.Notification procedure pursuant to Articles 14(2) and 16(5)

    6. Article 22D.Dossiers submitted to Rapporteur Member States before IP completion day

  6. CHAPTER 5 FINAL PROVISIONS

    1. Article 23.Repeal

    2. Article 24.Entry into force

  7. Signature

    1. Expand +/Collapse -

      ANNEX I

      Information requirements for notifications pursuant to Article 17

      1. A notification pursuant to Article 17 shall contain the following...

      2. evidence that the substance is an existing active substance within...

    2. Expand +/Collapse -

      ANNEX II

      SUBSTANCE/PRODUCT-TYPE COMBINATIONS INCLUDED IN THE REVIEW PROGRAMME ON 6 NOVEMBER 2018

      1. Active substance/product-type combinations supported on 6 November 2018 , excluding any...

    3. Expand +/Collapse -

      ANNEX III

      Time limits

Back to top

Options/Help